| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/11/2004 | US6734173 HSP DNA vaccines |
| 05/11/2004 | US6734169 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 05/11/2004 | US6734168 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/11/2004 | US6734166 Method of reducing aluminum levels in the central nervous system |
| 05/11/2004 | US6734165 Method for re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide |
| 05/11/2004 | US6734163 Administering composition of tissure factor pathway inhibitor, homolog or active fragment with anti-proliferative activity; treating angiogenesis related diseases; cancer; arthritis; macular degeneration; diabetic retinopathy |
| 05/11/2004 | US6734162 Mixture of buffer, zinc, phenolic preservative and isotonic agent |
| 05/11/2004 | US6734161 Peptide nucleic acids having antibacterial activity |
| 05/11/2004 | US6734160 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 05/11/2004 | US6734017 Gene expression inhibition; antiproliferative, anticancer and antiarthritic agents; angiogenesis inhibitors |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734006 Used to regulate extracellular matrix degradation, treats chronic obstructive pulmonary disease (copd) metastasis of malignant cells, tumor angiogenesis, inflammation, atherosclerosis and neurodegenerative diseases |
| 05/11/2004 | US6734003 Phosphodiesterase 10 |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733992 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733988 For suppression of cross-link formation |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733973 Diagnostic reagents for human cytomegalovirus and methods of use |
| 05/11/2004 | US6733791 Sublingual compositions comprising thymosin fraction 5 and methods for administration thereof |
| 05/11/2004 | US6733786 Under cold temperature; lipid soluble vitamin; alcohol, fatty acid, fatty ester or lubricant; cattle |
| 05/11/2004 | US6733762 Method of using Zot to inhibit lymphocyte proliferation in an antigen-specific manner |
| 05/11/2004 | US6733760 Recombinant toxin A/toxin B vaccine against Clostridium difficile |
| 05/11/2004 | US6733758 Fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 05/11/2004 | US6733757 Adeno-associated virus capsid polypeptide for use as gene transfer tool in cell tranduction |
| 05/11/2004 | US6733755 Ligand for vascular endothelial growth factor receptor |
| 05/11/2004 | US6733753 Composition and method for treating inflammatory diseases |
| 05/11/2004 | US6733752 Antibody specifically binds to p185; breast cancer |
| 05/11/2004 | US6733749 Comprises lytic enzyme composition for infecting bacteria (streptococcus pheumoniae and hemophilus influenza), and carrier (candy, lozenge, etc.) |
| 05/11/2004 | US6733130 Method for refracting and dispensing electro-active spectacles |
| 05/11/2004 | US6732738 Method to enhance healing of sternum after sternotomy |
| 05/11/2004 | CA2302033C Methods and compositions for enhanced wound healing |
| 05/11/2004 | CA2284482C Treatment of cardiomyopathy |
| 05/11/2004 | CA2074188C Vector with multiple tat activation response elements affecting gene expression |
| 05/07/2004 | CA2448481A1 A cell therapy method for the treatment of tumors |
| 05/07/2004 | CA2413981A1 Method for providing natural therapeutic agents with high therapeutic index |
| 05/06/2004 | WO2004038416A1 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6) |
| 05/06/2004 | WO2004038407A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
| 05/06/2004 | WO2004038406A2 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) |
| 05/06/2004 | WO2004038405A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 05/06/2004 | WO2004038021A1 Gpr54 knock-out mammals and screening methods using them |
| 05/06/2004 | WO2004038019A2 Dnazyme cleaving mutant polynucleotides |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004037997A2 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof |
| 05/06/2004 | WO2004037995A2 Methods for treating viral infection using il-28 and il-29 |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |
| 05/06/2004 | WO2004037860A1 Epididymis-specific gene as potential contraceptive target |
| 05/06/2004 | WO2004037859A1 Glp-1 derivatives and transmicosal absorption preparations thereof |
| 05/06/2004 | WO2004037858A2 Nipa, a nuclear interacting partner of anaplastic lymphoma kinase, polypeptides and use thereof |
| 05/06/2004 | WO2004037857A1 Bfk protein as therapeutic molecules |
| 05/06/2004 | WO2004037856A2 Plasmodium falciparum virulence factor var o |
| 05/06/2004 | WO2004037855A1 Macrocyclic peptides active against the hepatitis c virus |
| 05/06/2004 | WO2004037854A1 Prion protein-binding peptide sequences |
| 05/06/2004 | WO2004037851A2 Colostrinin and peptides thereof as modulators of intracellular signaling molecules and inhibitors of apoptosis |
| 05/06/2004 | WO2004037295A1 Method and agent for treating vulnerable plaque |
| 05/06/2004 | WO2004037288A1 Agent eleveting dendritic cell precursor level in blood |
| 05/06/2004 | WO2004037283A1 Bowman-birk inhibitor concentrate product and process |
| 05/06/2004 | WO2004037281A1 Methods for neuroprotection |
| 05/06/2004 | WO2004037280A1 Angiogenesis inducer |
| 05/06/2004 | WO2004037279A1 Method for treating patients with massive blood loss |
| 05/06/2004 | WO2004037278A2 Delocalization molecules and use thereof |
| 05/06/2004 | WO2004037277A2 Use of ingap for reversing diabetes |
| 05/06/2004 | WO2004037245A1 Combination of a growth hormone receptor antagonist such as pegvisomant and a cox-2 inhibitor such as celecoxib for the treatment of headache in patients with acromegaly |
| 05/06/2004 | WO2004037235A2 Method and composition for preventing and treating solid tumors |
| 05/06/2004 | WO2004037209A2 METHODS TO PREVENT TUMOR RECURRENCE BY BLOCKADE OF TGF-β |
| 05/06/2004 | WO2004037208A2 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 05/06/2004 | WO2004037205A2 LOW DOSE METHODS FOR TREATING DISORDERS IN WHICH TNFα ACTIVITY IS DETRIMENTAL |
| 05/06/2004 | WO2004037202A2 Gb virus c and methods of treating viral infections |
| 05/06/2004 | WO2004037198A2 Antibody-mediated induction of tumor cell death |
| 05/06/2004 | WO2004037196A2 Cytomodulating peptides and methods for treating neurological disorders |
| 05/06/2004 | WO2004037195A2 Treatment of diabetes |
| 05/06/2004 | WO2004037192A2 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 05/06/2004 | WO2004037184A2 Methods for the treatment of skin disorders |
| 05/06/2004 | WO2004037182A2 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | WO2004037168A2 Treatment of pancreatitis with amylin |
| 05/06/2004 | WO2004037167A2 Methods of treating dry eye disease with lantibiotics |
| 05/06/2004 | WO2004037164A2 Crosslinked compounds and methods of making and using thereof |
| 05/06/2004 | WO2004022700A3 Antifreeze proteins isolated from forage grasses and methods for their use |
| 05/06/2004 | WO2004021992A9 Delivery of therapeutics to the brain and spinal cord |
| 05/06/2004 | WO2004016648A8 Fluorescent protein |
| 05/06/2004 | WO2004015113A3 Albumin-fused ciliary neurotrophic factor |
| 05/06/2004 | WO2004011018A3 Methods of identifying selective beta-1-adrenergic receptor antagonists |
| 05/06/2004 | WO2004007536A3 Interactions of the epstein-barr virus protein ebna1, and uses thereof |
| 05/06/2004 | WO2004004750A3 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 05/06/2004 | WO2004003174A3 Method of up-regulating tumor antigen expression using thymalfasin |
| 05/06/2004 | WO2004001068A3 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 05/06/2004 | WO2004000042A3 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 05/06/2004 | WO2003105893A3 Probiotic therapies using lactobacillus reuteri |
| 05/06/2004 | WO2003105891A3 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 05/06/2004 | WO2003099318A3 Pancreas-specific proteins |
| 05/06/2004 | WO2003096964A3 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac |
| 05/06/2004 | WO2003093480A3 Immortalized hypothalamic neuronal cell lines |
| 05/06/2004 | WO2003093291A3 Antisense oligonucleotides for identifying drug targets and enhancing cancer therapies |
| 05/06/2004 | WO2003090695A3 TREATMENT OF α-GALACTOSIDASE A DEFICIENCY |
| 05/06/2004 | WO2003086470A3 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 05/06/2004 | WO2003079966A3 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 05/06/2004 | WO2003078572A3 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
| 05/06/2004 | WO2003076577A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/06/2004 | WO2003051837A8 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 05/06/2004 | WO2003050502A9 Prospective identification and characterization of breast cancer stem cells |